UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 11, 2015
Merge Healthcare Incorporated
(Exact name of registrant as specified in its charter)
Delaware
|
|
001–33006
|
|
39-1600938
|
(State of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S Employer Identification No.)
|
|
|
|
|
|
350 North Orleans Street, 1st Floor
|
|
|
|
|
Chicago, Illinois
|
|
|
|
60654
|
(Address of Principal Executive Offices)
|
|
|
|
(ZIP Code)
|
|
|
|
|
|
|
|
(312) 565-6868
|
|
|
(Registrant’s telephone number, including area code)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17-CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
This Form 8-K is being filed in order to update the unaudited pro forma financial information reflecting to our acquisition of D.R. Systems, Inc. (“DR Systems”) through the three months ended March 31, 2015. On February 25, 2015, as reported in our Current Report on Form 8-K filed on March 3, 2015, we acquired 91.5% of the common stock of DR Systems. As of April 17, 2015, we acquired the remaining common stock of DR Systems and it is now a 100% owned subsidiary of Merge.
Item 9.01
|
|
Unaudited Pro Forma Condensed Consolidated Financial Information.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
MERGE HEALTHCARE INCORPORATED
|
|
|
|
May 11, 2015
|
|
/s/ Steven M. Oreskovich
|
|
|
By: Steven M. Oreskovich
|
|
|
Title: Chief Financial Officer
|
Exhibit 99.1
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS
(in thousands, except share data)
The following unaudited pro forma condensed consolidated financial statement is based upon the historical financial statements of Merge Healthcare Incorporated (“Merge,” “we,” “us” or “our”) and D.R. Systems, Inc. (“DR Systems”) after giving effect to our acquisition of 91.5% of the issued and outstanding shares of DR Systems on February 25, 2015, followed by our acquisition of the remaining 8.5% of the issued and outstanding shares of DR Systems as of April 17, 2015.
On February 25, 2015, we acquired 91.5% of the outstanding common shares and voting interest of DR Systems for cash consideration of $76,514. As of April 17, 2015, we acquired the remaining common stock of DR Systems for an estimated $7,104 and, as such, DR Systems became a 100% owned subsidiary of Merge. On February 25, 2015, we issued 50,000 shares of preferred stock, par value $0.01 per share, for an aggregate purchase price of $50,000 pursuant to a stock purchase agreement. We used the net proceeds to finance the acquisition of DR Systems and to pay fees related to the transactions.
The following unaudited pro forma condensed consolidated financial statement presents the historical statement of operations of Merge for the three months ended March 31, 2015, and the historical results of DR Systems for the period from January 1, 2015 through February 25, 2015, giving pro forma effect as if the acquisition and the preferred stock issuance had occurred on January 1, 2014.
The historical financial information has been adjusted to give effect to pro forma events that are directly attributable to the preferred stock issuance and the acquisition, are factually supportable and have a recurring impact. The unaudited pro forma condensed combined statement of operations is not necessarily indicative of the results of operations that may have actually occurred had the acquisition taken place on the dates noted, or the future operating results of the combined company. The pro forma adjustments are based upon available information and assumptions that we believe are reasonable.
The acquisition of DR Systems was accounted for in accordance with ASC Topic No. 805, Business Combinations. The total purchase price was allocated to the net tangible and intangible assets acquired and liabilities assumed using estimates made by us based on the work performed by independent valuation specialists, primarily through the use of discounted cash flow techniques. The allocation of the purchase price used in this unaudited pro forma condensed consolidated statement of operations is preliminary and we expect to make adjustments, some of which could be material, until such time that we complete the final purchase price allocation.
Subsequent to the acquisition of DR Systems, we reversed a portion of a deferred tax asset valuation allowance that had been established against our net deferred tax assets related to U.S. consolidated federal and state jurisdictions. The release of this valuation allowance was not a direct result of our acquisition of DR Systems and occurred after the acquisition. The acquisition included additional sources of taxable income such as the reversal of temporary differences that are available to offset our deferred tax assets in future periods. The net income impact of the tax valuation allowance release was a tax benefit of approximately $18.4 million in 2015. Merge has significant net operating loss carryforwards for federal income tax purposes and has, therefore, assumed no additional income tax expense in the unaudited pro forma condensed consolidated statement of operations in connection with this pro forma financial information.
The preferred stock issuance was accounted for in accordance with ASC Topic 480-10-S99-3A, SEC Staff Announcement: Classification and Measurement of Redeemable Securities. We have excluded the impact of the amortization of the beneficial conversion feature and the accretion to redemption value recognized in the three months ended March 31, 2015, from preferred stock dividends and dividend equivalents in the unaudited pro forma condensed consolidated statement of operations for March 31, 2015, as they are nonrecurring. We have included the 8.5% preferred stock dividend in the unaudited pro forma condensed consolidated statement of operations for the three months ended March 31, 2015, as if the preferred stock had been issued on January 1, 2014 and a quarterly dividend had been paid.
The unaudited pro forma condensed consolidated statement of operations does not reflect the impact of any potential operational efficiencies, cost savings or economies of scale that Merge may achieve with respect to the combined operations. We have already incurred and anticipate incurring costs related to the preferred stock issuance and the acquisition. Based upon information available at the date of preparation of this pro forma financial statement, we anticipate total costs of the acquisition to be incurred will approximate $0.4 million for the acquisition.
The unaudited pro forma condensed consolidated financial statement should be read in conjunction with the historical consolidated financial statements and accompanying notes contained in the following:
|
· |
Merge’s Annual Report on Form 10-K for the year ended December 31, 2014; |
|
· |
Merge’s Quarterly Report on Form 10-Q for the three months ended March 31, 2015; |
|
· |
Merge’s Current Report on Form 8-K/A filed on May 11, 2015. See Exhibit 99.1 for the DR Systems’ audited financial statements for the years ended December 31, 2014 and December 31, 2013. |
MERGE HEALTHCARE INCORPORATED
|
|
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
For the Three Months Ended March 31, 2015
|
|
(In thousands, except for share data)
|
|
|
|
|
|
Historical Merge
|
|
|
Historical DR Systems January 1 through February 25, 2015
|
|
|
Pro Forma Adjustments
|
|
|
|
|
Pro Forma Combined
|
|
|
|
|
|
|
|
|
|
(Note 3)
|
|
|
|
|
|
|
Net sales
|
|
$
|
54,403
|
|
|
$
|
6,628
|
|
|
$
|
-
|
|
|
|
|
$
|
61,031
|
|
Cost of sales
|
|
|
22,227
|
|
|
|
1,024
|
|
|
|
486
|
|
(1
|
)
|
|
|
23,737
|
|
Gross margin
|
|
|
32,176
|
|
|
|
5,604
|
|
|
|
(486
|
)
|
|
|
|
|
37,294
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
8,978
|
|
|
|
585
|
|
|
|
-
|
|
|
|
|
|
9,563
|
|
Product research and development
|
|
|
8,228
|
|
|
|
1,528
|
|
|
|
-
|
|
|
|
|
|
9,756
|
|
General and administrative
|
|
|
7,512
|
|
|
|
2,880
|
|
|
|
-
|
|
|
|
|
|
10,392
|
|
Acquisition-related expenses
|
|
|
351
|
|
|
|
-
|
|
|
|
(351
|
)
|
(2
|
)
|
|
|
-
|
|
Restructuring and other expenses
|
|
|
1,178
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
1,178
|
|
Depreciation and amortization
|
|
|
2,099
|
|
|
|
24
|
|
|
|
291
|
|
(3
|
)
|
|
|
2,414
|
|
Total operating costs and expenses
|
|
|
28,346
|
|
|
|
5,017
|
|
|
|
(60
|
)
|
|
|
|
|
33,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
3,830
|
|
|
|
587
|
|
|
|
(426
|
)
|
|
|
|
|
3,991
|
|
Other income (expense)
|
|
|
(4,526
|
)
|
|
|
3
|
|
|
|
-
|
|
|
|
|
|
(4,523
|
)
|
Income (loss) before income taxes
|
|
|
(696
|
)
|
|
|
590
|
|
|
|
(426
|
)
|
|
|
|
|
(532
|
)
|
Income tax expense (benefit)
|
|
|
(18,391
|
)
|
|
|
53
|
|
|
|
-
|
|
(4
|
)
|
|
|
(18,338
|
)
|
Net income
|
|
|
17,695
|
|
|
|
537
|
|
|
|
(426
|
)
|
|
|
|
|
17,806
|
|
Less: noncontrolling interest's share
|
|
|
(76
|
)
|
|
|
-
|
|
|
|
76
|
|
(5
|
)
|
|
|
-
|
|
Net income attributable to Merge
|
|
|
17,771
|
|
|
|
537
|
|
|
|
(502
|
)
|
|
|
|
|
17,806
|
|
Less: preferred stock dividends and dividend equivalents related to accretion
|
|
|
5,328
|
|
|
|
-
|
|
|
|
(4,265
|
)
|
(6
|
)
|
|
|
1,063
|
|
Net income attributable to common shareholders of Merge
|
|
$
|
12,443
|
|
|
$
|
537
|
|
|
$
|
3,763
|
|
|
|
|
$
|
16,743
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share attributable to common shareholders of Merge - basic
|
|
$
|
0.11
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.15
|
|
Weighted average number of common shares outstanding - basic
|
|
|
96,616,916
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96,616,916
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share attributable to common shareholders of Merge - diluted
|
|
$
|
0.11
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.15
|
|
Weighted average number of common shares outstanding - diluted
|
|
|
98,017,786
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98,017,786
|
|
Note 1.
|
Basis of Pro Forma Presentation
|
On February 25, 2015, we acquired 91.5% of the outstanding common shares and voting interest of DR Systems for cash consideration of $76,514. As of April 17, 2015, we acquired the remaining common stock of DR Systems for an estimated $7,104 and, as such, DR Systems became a 100% owned subsidiary of Merge. On February 25, 2015, we issued 50,000 shares of Preferred Stock, par value $0.01 per share for an aggregate purchase price of $50,000 pursuant to a stock purchase agreement. We used the net proceeds to finance the acquisition of DR Systems and to pay fees related to the transactions.
The unaudited pro forma condensed consolidated financial statement is based on the historical financial statements of Merge and DR Systems after giving effect to the preferred stock issuance, the acquisition and certain pro forma adjustments.
The unaudited pro forma condensed consolidated statement of operations assumes that Merge’s acquisitions of DR Systems occurred on January 1, 2014. The Merge unaudited pro forma condensed consolidated statement of operations combines the historical results of Merge for the three months ended March 31, 2015, and the historical results of DR Systems for the period from January 1, 2015 to February 25, 2015, and includes pro forma adjustments.
The unaudited pro forma condensed consolidated financial data are presented for informational purposes only and are not necessarily indicative of the results of operations for future periods or the results that actually would have been realized had the acquisitions described above been consummated as of January 1, 2014.
Note 2.
|
Purchase Price and Preliminary Purchase Price Allocation
|
The total purchase price for DR Systems was $76,514 on February 25, 2015. As of April 17, 2015, we acquired the remaining common stock of DR Systems for an estimated $7,104.
The purchase price for DR Systems will be allocated to tangible and identifiable intangible assets acquired and liabilities assumed, based on their estimated fair values as of the date the acquisition is completed. The excess of the purchase price over the net tangible and identifiable intangible assets will be recorded as goodwill. Based upon a preliminary valuation, the preliminary purchase price for DR Systems would be allocated as set forth in the following table:
|
|
Estimated Fair Value
|
|
Cash
|
|
$
|
13,455
|
|
Other tangible assets
|
|
|
4,773
|
|
Deferred revenue
|
|
|
(11,196
|
)
|
Deferred tax liabilities
|
|
|
(18,817
|
)
|
Liabilities assumed
|
|
|
(4,446
|
)
|
Customer relationships
|
|
|
17,620
|
|
Trade names
|
|
|
420
|
|
Non-competes
|
|
|
280
|
|
Purchased software and technology
|
|
|
28,640
|
|
Goodwill
|
|
|
52,889
|
|
Total consideration
|
|
$
|
83,618
|
|
The preliminary allocation of the purchase price of DR Systems is based upon management’s estimates. These estimates and assumptions are subject to change upon final valuation.
Identifiable intangible assets subject to amortization: Identifiable intangible assets acquired that are subject to amortization include customer relationships, trade names, non-compete agreements with certain employees and purchased software and technology. Customer relationships represent the value of underlying relationships and agreements with customers. Trade names represent the fair value of marketing-related acquired assets. Purchased software and technology is comprised of products that have reached technological feasibility.
Estimated useful lives of intangible assets for the purposes of these pro forma statements are set forth in the following table:
Estimated useful lives of identified intangible assets:
|
|
Years
|
|
Amortization Method
|
|
|
|
|
|
Customer relationships
|
|
|
12.0
|
|
Straight-line
|
Trade names
|
|
|
2.0
|
|
Straight-line
|
Non-competes
|
|
|
4.0
|
|
Straight-line
|
Purchased software and technology
|
|
|
9.8
|
|
Straight-line
|
Goodwill
|
|
Indefinite
|
|
N/A
|
The pro forma results of operations include adjustments to recognize the effects of these intangible assets and the associated amortization. The DR Systems intangible assets subject to amortization are being amortized on a straight line basis, which approximates Merge’s historical treatment for the majority of such assets.
Note 3.
|
Pro Forma Adjustments
|
The following pro forma adjustments have been reflected in the unaudited pro forma condensed consolidated statement of operations for the three months ended March 31, 2015:
|
(1) |
To record amortization related to the purchased and developed software recognized from the acquisition DR Systems. |
|
(2) |
To remove acquisition expenses related to the DR Systems acquisition as they are nonrecurring. |
|
(3) |
To record amortization related to the customer relationships, trade names and non-compete agreements recognized from the acquisition of DR Systems. |
|
(4) |
The tax benefit of $18.4 million primarily relates to a deferred tax asset valuation allowance release recognized during the three months ended March 31, 2015. |
|
(5) |
To remove the noncontrolling interest’s effect in the three months ended March 31, 2015, since we have assumed the acquisition of DR Systems and all related transactions occurred on January 1, 2014, for this unaudited pro forma condensed consolidated statement of operations. |
|
(6) |
To remove nonrecurring preferred stock deemed dividend and accretion to redemption value recorded in the three months ended March 31, 2015, and to record the 8.5% annual preferred stock dividend for the period from January 1, 2015 through February 24, 2015, as if preferred stock issuance had occurred on January 1, 2014 and the dividend had been paid for the full three months ended March 31, 2015. |
|
|
Historical Merge
|
|
|
Pro Forma Adjustments
|
|
|
Pro Forma Combined
|
|
Preferred stock deemed dividend
|
|
$
|
4,349
|
|
|
$
|
(4,349
|
)
|
|
$
|
-
|
|
Preferred stock dividend equivalents related to accretion
|
|
|
566
|
|
|
|
(566
|
)
|
|
|
-
|
|
Preferred stock dividends paid or payable
|
|
|
413
|
|
|
|
650
|
|
|
|
1,063
|
|
|
|
$
|
5,328
|
|
|
$
|
(4,265
|
)
|
|
$
|
1,063
|
|